current affair
Bharat Biotech’s Covaxin has received the SEC recommendation for emergency use in children between the ages of 2 to 18 years.
from Jagran Josh https://ift.tt/3mKRp4F
via IFTTT
from Jagran Josh https://ift.tt/3mKRp4F
via IFTTT
Bharat Biotech’s Covaxin has received the SEC recommendation for emergency use in children between the ages of 2 to 18 years.
Post a Comment